MCI Multispecialty Grand Rounds: Updates in the Management of Metastatic Triple Negative Breast Cancer

Miami, FL US
October 14, 2019

Triple-negative breast cancer (TNBC) is associated with a high risk of recurrence and generally a bad prognosis. More than one-third of patients with TNBC will present distant metastases during the course of their disease.

During this conference Dr. Traina will discuss checkpoint inhibition in metastatic TNBC. Participants will also discover novel therapies in development for metastatic TNBC.  

 

    Locations

Live- MCI – Tumor Board Room - 3N110
Webcast 

Target Audience

Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, General Surgeons, General Practitioners, Obstetrics and Gynecologists, Oncologists, Radiation Oncologists, Nurses, Social Workers, Patient Navigators and all other interested healthcare professionals.

 

Learning Objectives

  • Identify relevant targets in TNBC.
  • Implement checkpoint inhibition in metastatic TNBC. 
  • Accurately assess novel therapies in development for metastatic TNBC. 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance
Course opens: 
08/05/2019
Course expires: 
01/25/2020
Event starts: 
10/14/2019 - 7:30am
Event ends: 
10/14/2019 - 8:30am
Rating: 
0
Miami Cancer Institute
8900 N. Kendall Dr
MCI – Tumor Board Room - 3N110
Miami, FL 33176
United States

Tiffany A. Traina, MD 
Vice Chair, Oncology Operations; Dept of Medicine
Clinical Director, Breast Medicine Service  
Section Head, Triple Negative Breast Cancer Clinical Research Program 

Tiffany A. Triana, M.D., indicated that she is a consultant for Genentech/Roche, AstraZeneca, Merck, Puma Biotechnology, Novartis, Innocrin Pharma, Astellas Pharma, Immunomedics, Daiichi Sankyo and Carrick Pharm, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 1 credit hour for Nursing, Nurse Practitioners, and Clinical Chaplains. Baptist Health South Florida CE Broker Provider #50-182.
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
08/05/2019
Course expires: 
01/25/2020
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
Please login or register to take this course.

NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support